Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials
Authors:
Top Cited Papers
- 29 January 2025
- journal article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 13 (3) , 221-233
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary InfectionsJAMA, 2024
- Measuring the performance of prediction models to personalize treatment choiceStatistics in Medicine, 2023
- From Real‐World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying ChallengesClinical Pharmacology & Therapeutics, 2020
- Individual participant data meta‐analysis to examine interactions between treatment effect and participant‐level covariates: Statistical recommendations for conduct and planningStatistics in Medicine, 2020
- Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired PneumoniaJAMA Internal Medicine, 2019
- Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching studyIntensive Care Medicine, 2018
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant DataJAMA, 2015
- Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory ResponseJAMA, 2015
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of internal medicine (1960), 2007
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002